Home › Drug Approved In Pivotal Studies Using DSG's Fully Electronic Source Data
 

Keywords :   


Drug Approved In Pivotal Studies Using DSG's Fully Electronic Source Data

2015-03-04 04:49:19| drugdiscoveryonline Home Page

DSG, Inc and Sirion Therapeutics collaborated in launching the industry’s first two pivotal Phase 3 studies using entirely electronic source data collection for the safety and efficacy of Difluprednate in the management of inflammation following ocular surgery

Tags: data source fully studies

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09When to recline and how to share armrests: Rules for avoiding a mid-flight row
29.09Atlantic Tropical Weather Outlook
29.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 12
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 12
28.09Hurricane Isaac Forecast Advisory Number 12
More »